753 related articles for article (PubMed ID: 29477239)
1. Advanced glycation end products in the pathogenesis of chronic kidney disease.
Rabbani N; Thornalley PJ
Kidney Int; 2018 Apr; 93(4):803-813. PubMed ID: 29477239
[TBL] [Abstract][Full Text] [Related]
2. Dicarbonyl-mediated AGEing and diabetic kidney disease.
Dimitropoulos A; Rosado CJ; Thomas MC
J Nephrol; 2020 Oct; 33(5):909-915. PubMed ID: 32170575
[TBL] [Abstract][Full Text] [Related]
3. Emerging Glycation-Based Therapeutics-Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors.
Rabbani N; Thornalley PJ
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269594
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease.
Rabbani N; Adaikalakoteswari A; Larkin JR; Panagiotopoulos S; MacIsaac RJ; Yue DK; Fulcher GR; Roberts MA; Thomas M; Ekinci E; Thornalley PJ
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613596
[TBL] [Abstract][Full Text] [Related]
5. Eucommia ulmoides Ameliorates Glucotoxicity by Suppressing Advanced Glycation End-Products in Diabetic Mice Kidney.
Do MH; Hur J; Choi J; Kim M; Kim MJ; Kim Y; Ha SK
Nutrients; 2018 Feb; 10(3):. PubMed ID: 29495397
[No Abstract] [Full Text] [Related]
6. High serum level of methylglyoxal-derived AGE, Nδ-(5-hydro-5-methyl-4-imidazolone-2-yl)-ornithine, independently relates to renal dysfunction.
Ito K; Sakata N; Nagai R; Shirakawa JI; Watanabe M; Mimata A; Abe Y; Yasuno T; Sasatomi Y; Miyake K; Ueki N; Hamauchi A; Nakashima H
Clin Exp Nephrol; 2017 Jun; 21(3):398-406. PubMed ID: 27344336
[TBL] [Abstract][Full Text] [Related]
7. Methylglyoxal stress, the glyoxalase system, and diabetic chronic kidney disease.
Hanssen NMJ; Stehouwer CDA; Schalkwijk CG
Curr Opin Nephrol Hypertens; 2019 Jan; 28(1):26-33. PubMed ID: 30320620
[TBL] [Abstract][Full Text] [Related]
8. Glyoxalase 1 Modulation in Obesity and Diabetes.
Rabbani N; Thornalley PJ
Antioxid Redox Signal; 2019 Jan; 30(3):354-374. PubMed ID: 29160087
[No Abstract] [Full Text] [Related]
9. Methylglyoxal-derived advanced glycation end products contribute to negative cardiac remodeling and dysfunction post-myocardial infarction.
Blackburn NJR; Vulesevic B; McNeill B; Cimenci CE; Ahmadi A; Gonzalez-Gomez M; Ostojic A; Zhong Z; Brownlee M; Beisswenger PJ; Milne RW; Suuronen EJ
Basic Res Cardiol; 2017 Sep; 112(5):57. PubMed ID: 28864889
[TBL] [Abstract][Full Text] [Related]
10. Methylglyoxal-induced dicarbonyl stress in aging and disease: first steps towards glyoxalase 1-based treatments.
Rabbani N; Xue M; Thornalley PJ
Clin Sci (Lond); 2016 Oct; 130(19):1677-96. PubMed ID: 27555612
[TBL] [Abstract][Full Text] [Related]
11. Protein Glycation in Plants-An Under-Researched Field with Much Still to Discover.
Rabbani N; Al-Motawa M; Thornalley PJ
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486308
[TBL] [Abstract][Full Text] [Related]
12. Multiple roles of glyoxalase 1-mediated suppression of methylglyoxal glycation in cancer biology-Involvement in tumour suppression, tumour growth, multidrug resistance and target for chemotherapy.
Rabbani N; Xue M; Weickert MO; Thornalley PJ
Semin Cancer Biol; 2018 Apr; 49():83-93. PubMed ID: 28506645
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation endproducts, dityrosine and arginine transporter dysfunction in autism - a source of biomarkers for clinical diagnosis.
Anwar A; Abruzzo PM; Pasha S; Rajpoot K; Bolotta A; Ghezzo A; Marini M; Posar A; Visconti P; Thornalley PJ; Rabbani N
Mol Autism; 2018; 9():3. PubMed ID: 29479405
[TBL] [Abstract][Full Text] [Related]
14. Experimental Hyperglycemia Alters Circulating Concentrations and Renal Clearance of Oxidative and Advanced Glycation End Products in Healthy Obese Humans.
Perkins RK; Miranda ER; Karstoft K; Beisswenger PJ; Solomon TPJ; Haus JM
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30823632
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end products and the progressive course of renal disease.
Heidland A; Sebekova K; Schinzel R
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S100-6. PubMed ID: 11576932
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation.
Xue M; Rabbani N; Momiji H; Imbasi P; Anwar MM; Kitteringham N; Park BK; Souma T; Moriguchi T; Yamamoto M; Thornalley PJ
Biochem J; 2012 Apr; 443(1):213-22. PubMed ID: 22188542
[TBL] [Abstract][Full Text] [Related]
17. Gene doubling increases glyoxalase 1 expression in RAGE knockout mice.
Bartling B; Zunkel K; Al-Robaiy S; Dehghani F; Simm A
Biochim Biophys Acta Gen Subj; 2020 Jan; 1864(1):129438. PubMed ID: 31526867
[TBL] [Abstract][Full Text] [Related]
18. Increased peritoneal damage in glyoxalase 1 knock-down mice treated with peritoneal dialysis.
Kihm LP; Müller-Krebs S; Holoch S; Schmuck S; Becker LE; Brownlee M; Zeier M; Fleming TH; Nawroth PP; Schwenger V
Nephrol Dial Transplant; 2015 Mar; 30(3):401-9. PubMed ID: 25387474
[TBL] [Abstract][Full Text] [Related]
19. Identifying advanced glycation end products as a major source of oxidants in aging: implications for the management and/or prevention of reduced renal function in elderly persons.
Vlassara H; Uribarri J; Ferrucci L; Cai W; Torreggiani M; Post JB; Zheng F; Striker GE
Semin Nephrol; 2009 Nov; 29(6):594-603. PubMed ID: 20006791
[TBL] [Abstract][Full Text] [Related]
20. Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics.
Rabbani N; Xue M; Thornalley PJ
Glycoconj J; 2016 Aug; 33(4):513-25. PubMed ID: 27406712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
